PhRMA Sounds Alarm on “Huge Seller” Re-Pricing, Possible Decline in Japan Investment

Tony Alvarez, chairman, PhRMA Japan-based executive committee Tony Alvarez, Japan chief of the Pharmaceutical Research and Manufacturers of America (PhRMA), on December 11 reiterated the industry’s demand for the upcoming drug pricing reform next April, warning that proposed anti-innovation measures...read more